Jorge Arca-Suárez
Instituto de Salud Carlos III(ES)Instituto de Investigación Biomédica de A Coruña(ES)
Publications by Year
Research Areas
Antibiotic Resistance in Bacteria, Antibiotics Pharmacokinetics and Efficacy, Antibiotic Use and Resistance, Pneumonia and Respiratory Infections, Infections and bacterial resistance
Most-Cited Works
- → New Carbapenemase Inhibitors: Clearing the Way for the β-Lactams(2020)116 cited
- → Pseudomonas aeruginosa antibiotic susceptibility profiles, genomic epidemiology and resistance mechanisms: a nation-wide five-year time lapse analysis(2023)77 cited
- → Pseudomonas aeruginosa antimicrobial susceptibility profiles, resistance mechanisms and international clonal lineages: update from ESGARS-ESCMID/ISARPAE Group(2023)75 cited
- → Molecular mechanisms driving thein vivodevelopment of OXA-10-mediated resistance to ceftolozane/tazobactam and ceftazidime/avibactam during treatment of XDRPseudomonas aeruginosainfections(2020)60 cited
- → Activity of cefiderocol, imipenem/relebactam, cefepime/taniborbactam and cefepime/zidebactam against ceftolozane/tazobactam- and ceftazidime/avibactam-resistant Pseudomonas aeruginosa(2022)49 cited
- → Activity of imipenem/relebactam against a Spanish nationwide collection of carbapenemase-producing Enterobacterales(2021)46 cited
- → Molecular and biochemical insights into the in vivo evolution of AmpC-mediated resistance to ceftolozane/tazobactam during treatment of an MDR Pseudomonas aeruginosa infection(2020)40 cited
- → Emergence of 16S rRNA methyltransferases among carbapenemase-producing Enterobacterales in Spain studied by whole-genome sequencing(2021)29 cited
- → First identification of blaNDM-1 carbapenemase in blaOXA-94-producing Acinetobacter baumannii ST85 in Spain(2019)27 cited
- → Challenging Antimicrobial Susceptibility and Evolution of Resistance (OXA-681) during Treatment of a Long-Term Nosocomial Infection Caused by a Pseudomonas aeruginosa ST175 Clone(2019)27 cited